Skip to main content
. 2022 May 13;32(11):7578–7589. doi: 10.1007/s00330-022-08811-6

Fig. 1.

Fig. 1

Flowchart of patient selection. EOB-MRI, gadoxetic acid–enhanced magnetic resonance imaging; HCC, hepatocellular carcinoma; RFA, radiofrequency ablation; TACE, transcatheter arterial chemoembolization